Eyelid Lesions
Understanding Eyelid Lesions
If you have noticed an unusual bump, growth, or discolored patch on or near your eyelid, you are not alone, and we understand how unsettling it can be. Eyelid lesions are abnormal growths that develop on the eyelid skin, and they range from harmless cysts and skin tags to precancerous spots and malignant tumors. Because the eyelid skin is among the thinnest in the body and receives significant sun exposure over a lifetime, it is particularly susceptible to a wide variety of growths. Approximately 70 to 80 percent of eyelid lesions are benign, meaning most growths are not cancerous (PMC, 2021).
While most eyelid lesions turn out to be harmless, certain types can indicate precancerous changes or early-stage skin cancer. The earlier a concerning lesion is identified, the more treatment options are available, and the better the expected outcome. Our oculoplastic surgeon evaluates and treats the full spectrum of eyelid growths, helping you understand when a lesion needs monitoring and when it needs to be removed.
You should have any new or changing eyelid growth evaluated if it increases in size over weeks or months, bleeds or ulcerates without healing, causes loss of eyelashes in the surrounding area, or distorts the normal shape of your eyelid margin. A firm, painless nodule that feels fixed to deeper tissue or a growth with irregular borders, uneven coloring, or a pearly appearance also warrants a prompt examination. Even a previously stable lesion deserves re-evaluation if it begins to change in color, texture, or behavior.
Types of Eyelid Lesions
The majority of eyelid lesions are benign, meaning they are not cancerous and do not spread to surrounding tissue. Common benign growths include papillomas (skin tags), seborrheic keratoses (waxy, raised patches), cysts such as sudoriferous and epidermal inclusion cysts, and xanthelasma, which appear as yellowish deposits on the eyelid skin. Benign vascular lesions such as capillary hemangiomas and pyogenic granulomas also occur, particularly in younger patients. While these growths are not dangerous, they may cause irritation, obstruct your visual field, or create cosmetic concerns that lead you to seek removal.
Actinic keratoses are the most common precancerous lesions that develop on the eyelid. These rough, scaly patches result from cumulative ultraviolet exposure and carry a risk of progressing to squamous cell carcinoma (a type of skin cancer) if left untreated. Lentigo maligna is another precancerous condition that appears as a flat, irregularly pigmented patch, most often in older adults with a history of significant sun exposure. Early identification and treatment of precancerous lesions can prevent the development of invasive skin cancer.
Cancerous eyelid lesions account for roughly five to ten percent of all skin cancers in the head and neck region. Basal cell carcinoma (BCC) is the most common, representing 85 to 90 percent of eyelid malignancies (StatPearls, 2023), followed by squamous cell carcinoma, sebaceous gland carcinoma, and melanoma. These tumors can destroy normal eyelid architecture, compromise eye function, and in some cases spread beyond the eyelid. You can learn more about the specific types and their management on our dedicated eyelid cancer page.
Causes and Risk Factors
Chronic ultraviolet radiation is the single most significant risk factor for both benign and malignant eyelid lesions. The lower eyelid and the inner corner of the eye (medial canthus) receive particularly high levels of UV exposure because they are difficult to protect with hats or sunglasses alone. Over decades, this cumulative damage alters the DNA of eyelid skin cells, increasing the likelihood of abnormal growths. Wearing UV-blocking sunglasses and applying sunscreen to the face can reduce your long-term risk.
The natural aging process leads to changes in skin texture, oil gland function, and cellular repair mechanisms that make lesions more common with advancing age. Seborrheic keratoses, for example, are almost universal in adults over sixty. Similarly, excess eyelid skin from dermatochalasis can sometimes be mistaken for or occur alongside new eyelid growths, making a comprehensive examination important.
Fair skin, light eye color, a personal or family history of skin cancer, and a history of immunosuppression all increase the risk of malignant eyelid lesions. Hormonal changes and elevated cholesterol levels can contribute to specific benign growths like xanthelasma. Viral infections, including certain strains of human papillomavirus, are associated with squamous papillomas and some verrucae (warts) that appear on the eyelid. Chronic inflammation or irritation of the eyelid margin, sometimes related to conditions like chalazia or styes, can also encourage the formation of cysts and nodular growths.
How Eyelid Lesions Are Diagnosed
Our oculoplastic surgeon begins with a thorough clinical examination of the lesion using slit-lamp biomicroscopy (a specialized microscope) and magnification. We carefully document the location, size, shape, color, texture, and relationship to the eyelid margin. We also evaluate the surrounding structures, including the eyelashes, lacrimal drainage system (tear ducts), and conjunctival surfaces, because certain cancers such as sebaceous gland carcinoma can spread in ways that are not immediately visible on the skin surface.
When a lesion has suspicious features, a biopsy provides a definitive diagnosis. An excisional biopsy removes the entire lesion and sends it to a pathologist for microscopic analysis, while an incisional or punch biopsy samples a portion of a larger growth. The pathology report identifies the exact cell type involved, confirms whether the lesion is benign or malignant, and determines whether surgical margins are clear. This information directly shapes the surgical and reconstructive approach if further treatment is needed.
For lesions that appear to extend into deeper tissue or for suspected malignancies with aggressive features, imaging studies such as CT or MRI scans may be ordered. These scans help define the extent of the growth and guide surgical planning, particularly when a lesion may involve the orbit (the bony cavity surrounding the eye). Imaging is also important when a lesion recurs after initial treatment, as it can reveal involvement of structures not visible during a clinical examination alone. In cases where orbital tumors or growths are suspected, advanced imaging is an essential part of the diagnostic process.
Treatment Options for Eyelid Lesions
Not every eyelid lesion requires removal. When our oculoplastic surgeon determines that a growth is benign and not affecting your vision, comfort, or appearance, we may recommend periodic monitoring to watch for any changes over time. Some benign lesions, such as small cysts or chalazia that respond to warm compresses, can be managed conservatively without surgery.
When a benign lesion causes irritation, blocks your field of vision, or is cosmetically bothersome, we can remove it surgically in an outpatient setting. Our oculoplastic surgeon uses precise techniques to minimize visible scarring, placing incisions along natural skin creases whenever possible. The eyelid typically heals well because of its excellent blood supply, and scars from small excisions often become nearly imperceptible within a few months. Removed tissue is sent for pathologic analysis to confirm the diagnosis.
Treatment for malignant eyelid lesions typically involves surgical excision with careful margin control to ensure all cancer cells are removed while preserving as much healthy tissue as possible. Depending on the size and type of tumor, surgery may be performed using frozen section analysis or Mohs micrographic surgery, a technique that examines tissue layer by layer until clear margins are confirmed. For basal cell carcinoma treated early, the five-year survival rate is greater than 95 percent (multiple studies, 2023). Radiation therapy is sometimes used as an alternative or supplement for patients who are not candidates for surgery.
Reconstruction depends on the size and location of the tissue removed. Small defects involving less than a third of the eyelid margin can often be closed directly with sutures. Larger defects may require local tissue flaps, where adjacent skin and muscle are shifted to fill the gap, or grafts taken from the opposite eyelid, the inner cheek, or behind the ear. The goal of reconstruction is to restore a smooth eyelid contour, maintain proper eyelid closure and blinking function, and protect the surface of the eye. Our oculoplastic surgeon has completed fellowship training in oculoplastic surgery, which encompasses both the cancer removal and the reconstructive techniques needed to restore your eyelid.
Frequently Asked Questions
After a biopsy, the tissue sample is sent to a pathology laboratory for microscopic analysis. Results are typically available within five to ten business days, depending on the complexity of the case. If special stains or additional testing are needed, the process may take slightly longer. We contact you as soon as results are available to discuss findings and next steps.
For most benign lesions, removal has no negative effect on eyelid function. Our oculoplastic surgeon plans each excision to preserve the muscles and structures responsible for blinking and eyelid closure. In many cases, removing a lesion that was pressing on the eyelid or obstructing the visual field actually improves comfort and function after healing is complete.
Standard excision removes the lesion along with a surrounding margin of healthy tissue, which is then sent to a laboratory for analysis. Mohs micrographic surgery removes tissue one thin layer at a time, examining each layer under a microscope during the procedure itself. This real-time analysis allows for the highest cure rates while preserving the maximum amount of healthy eyelid tissue, making it particularly valuable for cancers in areas where tissue conservation is important.
Recurrence is possible with both benign and malignant lesions, though the rate varies by type. Benign cysts and chalazia may recur if underlying contributing factors such as chronic inflammation or excessive tearing persist. Malignant lesions have a small but real recurrence risk even after complete excision, which is why we recommend regular follow-up examinations for several years after treatment.
While not all eyelid lesions can be prevented, you can significantly reduce your risk of UV-related growths by wearing wraparound sunglasses with full ultraviolet protection and applying broad-spectrum sunscreen to your face and eyelid area. Avoiding tanning beds and wearing wide-brimmed hats during prolonged sun exposure also help. Regular self-checks of your eyelids for new or changing growths, combined with routine eye examinations, support early detection when prevention is not possible.
Coverage depends on whether the removal is considered medically necessary. Insurance typically covers excision of lesions that are suspicious for malignancy, cause symptoms such as visual obstruction or pain, or require biopsy for diagnostic purposes. Removal of lesions that are purely cosmetic in nature may not be covered. We recommend checking with your insurance provider before your procedure, and our team can assist with documentation to support medical necessity when appropriate.
What our Patients say
4.8
Reviews
(3547)